BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2157544)

  • 21. Diagnostic Accuracy of Mediastinal Lymph Node Staging Techniques in the Preoperative Assessment of Nonsmall Cell Lung Cancer Patients.
    Fréchet B; Kazakov J; Thiffault V; Ferraro P; Liberman M
    J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interobserver variability in CT and MR staging of lung cancer.
    Webb WR; Sarin M; Zerhouni EA; Heelan RT; Glazer GM; Gatsonis C
    J Comput Assist Tomogr; 1993; 17(6):841-6. PubMed ID: 8227566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchogenic carcinoma staging: CT versus MR imaging. Assessment with surgery.
    Laurent F; Drouillard J; Dorcier F; Velly JF; Barat JL; Grelet P; Martigne C; Tavernier J; Couraud L
    Eur J Cardiothorac Surg; 1988; 2(1):31-6. PubMed ID: 3272196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of lymph node size and metastatic involvement of lymph nodes in bronchial cancer].
    Vogel P; Daschner H; Lenz J; Schäfer R
    Langenbecks Arch Chir; 1990; 375(3):141-4. PubMed ID: 2162456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
    Liu BJ; Dong JC; Xu CQ; Zuo CT; Le JJ; Guan YH; Zhao J; Wu JF; Duan XH; Cao YX
    Chin Med J (Engl); 2009 Aug; 122(15):1749-54. PubMed ID: 19781319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
    Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The importance of mediastinoscopy for accurate lymph node staging].
    Kelm C; Henneking K; Zimmermann T; Padberg W
    Zentralbl Chir; 1996; 121(2):84-6. PubMed ID: 8868599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-small cell lung cancer: evaluation of node and metastatic staging].
    Brauner M; Brillet PY
    Rev Pneumol Clin; 2008 Oct; 64(5):245-9. PubMed ID: 18995154
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolated axillary lymph node metastasis at presentation in bronchogenic carcinoma.
    Krishnamurthy A; Neelakantan V
    J Cancer Res Ther; 2012; 8(1):161-2. PubMed ID: 22531544
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of computed tomography and mediastinoscopy in preoperative staging of lung carcinoma.
    Brion JP; Depauw L; Kuhn G; de Fracquen P; Friberg J; Rocmans ; Struyven J
    J Comput Assist Tomogr; 1985; 9(3):480-4. PubMed ID: 3989041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
    Schaarschmidt BM; Buchbender C; Nensa F; Grueneisen J; Gomez B; Köhler J; Reis H; Ruhlmann V; Umutlu L; Heusch P
    PLoS One; 2015; 10(1):e0116277. PubMed ID: 25574968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
    Gupta NC; Graeber GM; Bishop HA
    Chest; 2000 Mar; 117(3):773-8. PubMed ID: 10713005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MRI of bronchogenic carcinoma].
    Bittner RC; Nakamura T; Schörner W; Weiss T; Felix R
    Rinsho Hoshasen; 1989 Jan; 34(1):37-43. PubMed ID: 2724606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node size and metastatic infiltration in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Brochhagen HG; Schneider PM; Hölscher AH
    Chest; 2003 Feb; 123(2):463-7. PubMed ID: 12576367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging of mediastinal and hilar masses: comparison with CT.
    Levitt RG; Glazer HS; Roper CL; Lee JK; Murphy WA
    AJR Am J Roentgenol; 1985 Jul; 145(1):9-14. PubMed ID: 3873862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Bogaert J; Maes A; Deneffe GJ; Nackaerts KL; Verschakelen JA; Lerut TE; Mortelmans LA; Demedts MG
    J Clin Oncol; 1998 Jun; 16(6):2142-9. PubMed ID: 9626214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
    Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.